Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Cannabinoid (CB) receptor agonists have potential utility as anti‐inflammatory drugs for the treatment of many disease conditions. In the present study, we investigated the effects of the synthetic CB 2 ligand, JWH‐133 on the production of interleukins (ILs), IL‐12 and IL‐10 by lipopolyssacharide (LPS) or Theiler's virus (TMEV)‐activated macrophages. JWH‐133 evoked a concentration‐related inhibition (10 n M–5 μM) of LPS/IFN‐γ induced IL‐12p40 release. The effect of JWH‐133 (100 n M) was significantly blocked by the CB 2 antagonist SR‐144528 (1 μM). Macrophages infected with TMEV increased IL‐12p40 production and activation of CB 2 receptors by JWH‐133 (100 n M) inhibited it. The inhibitory effect of JWH‐133 (100 n M) on IL‐12p40 production may involve extracellular‐regulated kinase (ERK1/2) signaling: (i) JWH‐133 induced a greater and sustained activation of ERK1/2 kinase in comparison with the level of activation observed following LPS; (ii) the inhibition of ERK1/2 by the specific inhibitor PD98059 increased LPS‐induced IL‐12p40 production in the presence or absence of JWH‐133 suggesting a negative regulation of ERK pathway on IL‐12p40 biosynthesis. Activation of CB 2 receptors by JWH‐133 (10 n M–5 μ M) enhanced IL‐10 release by LPS/IFN‐γ‐activated macrophages and addition of SR144558 (1 μ M) totally blocked the effect of JWH (100 n M). Inhibition of ERK by PD98059 significantly suppressed IL‐10 production by LPS‐activated macrophages. Endogenous IL‐10 plays a modulatory role in IL‐12 production. Blocking IL‐10 with neutralizing antibody resulted in increased IL‐12p40 secretion by LPS‐activated macrophages in the absence or presence of JWH‐133. In contrast, the addition of exogenous mIL‐10 reduced the secretion of IL‐12p40 in response to LPS. British Journal of Pharmacology (2005) 145, 441–448. doi:10.1038/sj.bjp.0706215
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 1×
“Two CB G protein-coupled receptors have been cloned until now, CB1 receptors (Matsuda et al., 1990) expressed primarily by neurons, and CB2 receptors (Munro et al., 1993) expressed primarily by immune cells.”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., & Roth, M. D. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00370-3 · Cited by 234 · cited 1×
“Later studies using British Journal of Pharmacology vol 145 (4) activated peripheral blood T-cell cultures showed that treatment with THC inhibited cell proliferation and the generation of Th1 cytokines, including IL-12, by CB2-mediated mechanisms (Yuan et al., 2002).”
MethodOlson, J. K., Girvin, A. M., & Miller, S. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9780-9789.2001 · Cited by 178
Cited by
Beta-caryophyllene is a dietary cannabinoid.
Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803601105 · Cited by 906
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Cannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555
“The animals were then challenged with LPS.”
InfluentialProgramming dendritic cells to induce TH2 and tolerogenic responses
Pulendran, B., Tang, H., & Manicassamy, S. (2010) · Nature Immunology · doi:10.1038/ni.1894 · Cited by 355
Merighi, S., Gessi, S., Varani, K., Fazzi, D., Mirandola, P., & Borea, P. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01948.x · Cited by 79
“Furthermore, such activation protects against human microglial neurotoxicity by enhancing IL-10 production (Klegeris et al., 2003; Correa et al., 2005; 2010; Eljaschewitsch et al., 2006).”
Background
Metadata
- Authors
- Correa, F., Mestre, L., Docagne, F., & Guaza, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 145
- Issue
- 4
- Pages
- 441-448
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1896273345
- Cited by
- 131
- References
- 7
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling. https://app.cochat.ai/papers/10.1038/sj.bjp.0706215
- The paper
- Correa, F., Mestre, L., Docagne, F., & Guaza, C. (2005). Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.